Core Factors delivers a suite of type assessments supported by a participant experience designed to sustain learning ...

Funding and clinical trial-based barriers must be addressed to ensure success on the path to developing DMTs for Parkinson’s disease.

ImmunityBio (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced the successful completion of manufacturing engineering programs, NK2022 and NK2023, establishing a safe, ...

In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from animal testing toward new approaches. One year later, much speculation ...

Drug discovery has traditionally been a reductive process—narrowing down, filtering out, and optimizing within established ...

G-Stacker has announced the availability of its digital infrastructure platform designed to automate the development of interconnected Google properties. The software operates as a technical solution ...

APL is developing a comprehensive suite of capabilities to ensure that additively manufactured parts can perform predictably in mission-critical applications — no matter where, when, or on what ...

Understand the impact of IND delays on biotechnology companies and how they affect early-stage development and funding.

Integration of non-communicable diseases (NCDs) prevention, screening and treatment into maternal, newborn and child healthcare (MNCH) services has become increasingly important as countries address ...

LONDON, UNITED KINGDOM, March 9, 2026 / EINPresswire.com / — Live Digital has launched a new website outlining its recruitment services and sector specialisms across product, growth, data, and ...

Discover why biomarkers are critical in modern drug discovery and clinical trials, enabling better target validation.